Explore

Rapid Read Rapid Read
Mammo 2026 Congress Highlights Advances in Breast Cancer Care

Mammo 2026 Congress Highlights Advances in Breast Cancer Care

The Mammo 2026 OncoDaily Breast Cancer Congress is a global virtual event focused on advancing breast cancer care through early diagnosis, risk stratification, and innovative treatment strategies. The congress addresses the global health priority of breast cancer, which is the most commonly diagnosed cancer worldwide. With over 2.3 million new cases annually, the congress emphasizes the importance of early detection and advanced care in improving survival rates. The event features a comprehensive program exploring the full clinical spectrum of breast cancer, including contemporary approaches to screening, risk-adapted decision-making, and innovative strategies for metastatic and triple-negative breast cancer.
Discover daily Discover daily
The Ballpark That Became the Pirates' Greatest Asset

The Ballpark That Became the Pirates' Greatest Asset

Forbes Field was more than just a ballpark for the Pittsburgh Pirates; it was a symbol of the team's identity and a cornerstone of their success. I...
Trendline Trendline
Novo Nordisk's IL-6 Inhibitor Ziltivekimab Fails in Cardiovascular Phase 3 Trial, Shares Drop

Novo Nordisk's IL-6 Inhibitor Ziltivekimab Fails in Cardiovascular Phase 3 Trial, Shares Drop

Novo Nordisk's IL-6 Inhibitor Ziltivekimab Fails in Cardiovascular Phase 3 Trial, Shares Drop
Rapid Read Rapid Read
UNC5B Signaling Identified as Key Driver in Pancreatic Cancer Metastasis

UNC5B Signaling Identified as Key Driver in Pancreatic Cancer Metastasis

Recent research has identified the UNC5B receptor as a significant factor in the progression of pancreatic ductal adenocarcinoma (PDAC), a type of pancreatic cancer. The study, conducted using genetically engineered mouse models, demonstrated that UNC5B is highly expressed in PDAC and plays a crucial role in the epithelial-to-mesenchymal transition (EMT), a process that facilitates cancer metastasis. The research highlights the potential of NP137, an antibody drug that inhibits the Netrin-1/UNC5B interaction, as a therapeutic option to prevent EMT and metastasis in PDAC. This discovery opens up new avenues for clinical trials aimed at testing the efficacy of NP137 in human pancreatic cancer patients.
Trendline Trendline
Orano Med Reports Progress in Nuclear Medicine and Business Outlook

Orano Med Reports Progress in Nuclear Medicine and Business Outlook

Orano Med Reports Progress in Nuclear Medicine and Business Outlook
TheStreet TheStreet
J&J’s biotech progress could punish its 2027 profit

J&J’s biotech progress could punish its 2027 profit

Johnson & Johnson (JNJ) just issued one of the weirdest profit warnings in health care. The biotech business decreased its 2026 adjusted earnings guidance to between $10.96 and $11.11 a share, from a range of $11.60 to $11.75. This year, the newly closed acquisition of Firefly Bio and the ...
SB Nation SB Nation
Pittsburgh Pirates vs. Cincinnati Reds: Paul Skenes vs. Hunter Greene

Pittsburgh Pirates vs. Cincinnati Reds: Paul Skenes vs. Hunter Greene

The Pirates are on the road looking to grab a win today.
Trendline Trendline
Novo Nordisk Faces Setback as Heart Drug Trial Fails, Impacting Stock Value

Novo Nordisk Faces Setback as Heart Drug Trial Fails, Impacting Stock Value

Novo Nordisk Faces Setback as Heart Drug Trial Fails, Impacting Stock Value
Trendline Trendline
Abington Minors Baseball Team Triumphs Over St. Marys with Strong Defense

Abington Minors Baseball Team Triumphs Over St. Marys with Strong Defense

Abington Minors Baseball Team Triumphs Over St. Marys with Strong Defense
Rapid Read Rapid Read
Indiana University of Pennsylvania's New Medical School Draws Over 500 Applicants for Inaugural Class

Indiana University of Pennsylvania's New Medical School Draws Over 500 Applicants for Inaugural Class

Indiana University of Pennsylvania (IUP) has launched a new College of Osteopathic Medicine, attracting significant interest from prospective students. Since admissions opened in May, over 500 applicants have completed their applications to join the inaugural class set to begin in fall 2027. The school, which will be the fourth college of osteopathic medicine in Pennsylvania, aims to address healthcare access in rural areas. The college has received pre-accreditation status, allowing it to recruit and admit students. Interviews are set to begin in the fall, with acceptance letters expected in November. The program is designed to resonate with students from rural communities, aligning with IUP's mission to address the shortage of physicians in these areas.
Rolling Stone Rolling Stone
How 26 Golden Retrievers Took Over Stateside

How 26 Golden Retrievers Took Over Stateside

And why we were totally OK with that
Trendline Trendline
Steve Bisciotti's Impact on Baltimore Ravens and Community Initiatives

Steve Bisciotti's Impact on Baltimore Ravens and Community Initiatives

Steve Bisciotti's Impact on Baltimore Ravens and Community Initiatives